Member Info for Doc83

Nope, don’t get it at all. You bought back in at a lower cost, but still bought into a company you have no confidence in.

Careful, Axe. You’ve got Andybe4 who’s outright mental, Professionot who’s full of BS. MrCosts who whines more than my missus. Don’t be the one who’s just plain thick.

https://www.mayoclinic.org/diseases-conditions/narcissistic-personality-disorder/symptoms-causes/syc-20366662

If we are waiting on strive and it is months away, it’s unthinkable how bad it will get on here. It’s already pretty intolerable.

Axe, LOL! Thick? I’m not the one who sold my shares then bought them back despite thinking the company is a dud.

Doh!

TipTop09 - see my post from yesterday at 18:10 ;)

Thanks, Dozzawba. Unfortunately it seems Philip Malone is getting about as much joy as MATD have... not a lot.

Axe - so you want to make money, but invested in a company that you say:

"the only thing that moves slower than this is not a Glacier, it is SNG concrete, embedded in more concrete smothered in Marmite frozen to -100 degrees!"

Doh!

Axe - why did you buy back in again?

HSD - maybe. Out of interest, what would it cost them for you to hand your shares over?

I've been a little surprised Polygon haven't increased their holding from 28.15% since 5th October to 29.99%. After all, it would only cost them approximately £500k... a nothing amount when they've presumably already spent £50-60m and would reduce their average in price by about 5p per share. It is possible they have a strict buying process in place and perhaps, just for example, they have said the final tranche they would buy has to be sub 10p. Another possibility is that they have lost confidence but know they can't unload 60m shares into the market.

Or, and a more left field possibility is that they have been made insiders. It is not entirely uncommon for large shareholders to be made insiders but they are usually restricted from being able to buy or sell any shares and must of course keep the information confidential.

Keen to hear possible other reasons why they've not spent relative pennies to get to that 29.99% and reduce that in price ever further.

HSD - Aether is referring to Janssen. They are owned by J&J and are joining up with SNG on an observational only trial called UNIVERSAL. On the face of it, it looks possibly insignificant but we'll see.

As for how much cash we have left, this has been discussed at length recently but some of the more sensible posters seem to accept we have plenty to keep the lights on for a good while yet, beyond this year. There have been no cost saving measures announced as yet. The hope is still a platform trial or JV. The curve ball thrown is a job advert for an Associate Director of Medical Affairs in the US on up to $300k.... a red herring or something more???

Hi Lockie - do you have inside information from the company that confirms nothing is going on behind the scenes that the rest of us and the market aren't aware of?

From the man who claimed to be a woman. And from someone who claimed to be *** but is not. Disgraceful.

Really, the oddest of the odd characters. What must your wife and kids back home in the US think of you... a dreadful disappointment probably :/

This might end up at 0p and be a bad investment choice, but TF I'm not deranged.

DOC83 - so it took you all day to actually divulge this little nugget?

Axe, I’ve had a helluva hangover today. This was the earliest I could bear to log on here ;)

Leroy, dead duck?

I was discussing Synairgen last night over a few beers on a sailing boat with my good mate Dickie who is HEAVILY involved with the company. I told him there are a lot of despondent people on the LSE BB who think it’s all over and he said something along the lines of:

“You’ve got to be kidding. They know we can’t discuss what’s going on behind the scenes but we’ve given them plenty of hints with the J&J/Janssen universal hook up, cos those guys are not going to fu4k around with a tiny British biotech just for some observational trial when they could do that themselves easier back in the much bigger US. Hell, we’ve even posted a senior job advert over in the US on hefty money in all the big J&J locations, even their f’ing headquarters in New Brunswick NJ where there’s only a population of 55k FFS.
We’ve been told to apply for strive but it’s pi55 take slow… only Shionogi are on it so far with big delays but we’ve been tipped the wink from the NIH who passed us through to P3 on the Activ-2 trial, but changes in SOC meant it was pointless continuing there. They can’t have been clearer though and said themselves “SNG001 merits further investigation”.
So yeah, I don’t know what other breadcrumbs we can leave lying around without us getting sent to jail.”

I’d had a few beers to could have misheard all of that.

Wigster - far too many keyboard warriors on here who should never have invested in a small biotech company.

Prof - trolls who come on here to deliberately provoke, thinking they are anonymous, ought to be careful. Because in 5 minutes I’ve managed to learn an incredible amount about one such poster and his life. Fortunately for him, I’m not mental and will keep it to myself as a private chuckle. He might think he’s a smart ar5e but there are others who might take what he writes personally and are perhaps as mad as he is.

LOL, Beardy and co working late and hard on a Friday!

I was hoping to have seen the presentation on ACTIV-2 from earlier in the week :/

Lebus - how do we know he has failed? He could have multiple trials and JVs lined up for all we know.